{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:34:00Z","timestamp":1793334840075,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118863","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T23:13:33Z","timestamp":1764717213000},"page":"118863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Innovative CAR-T approaches targeting Claudin 18.2 to counteract drug resistance in gastric cancer"],"prefix":"10.1016","volume":"193","author":[{"given":"Giovanni","family":"Calice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7069-4189","authenticated-orcid":false,"given":"Tiziana","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118863_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118863_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118863_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: A systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2025.118863_bib4","first-page":"18","article-title":"Familial gastric cancer: detection of a hereditary cause helps to understand its etiology","volume":"10","author":"Vogelaar","year":"2012","journal-title":"Hered. Cancer Clin. Pr."},{"key":"10.1016\/j.biopha.2025.118863_bib5","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.ejca.2009.04.019","article-title":"Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies","volume":"45","author":"Yang","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118863_bib6","first-page":"58","article-title":"Familial and hereditary gastric cancer, an overview","author":"Carneiro","year":"2022","journal-title":"Best. Pr. Res Clin. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118863_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118863_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","article-title":"Helicobacter pylori and gastric cancer: mechanisms and new perspectives","volume":"18","author":"Duan","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.118863_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.gene.2014.05.064","article-title":"The effect of Helicobacter pylori CagA on the HER-2 copy number and expression in gastric cancer","volume":"546","author":"Shim","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2025.118863_bib10","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/S1470-2045(14)71016-2","article-title":"Familial gastric cancer: genetic susceptibility, pathology, and implications for management","volume":"16","author":"Oliveira","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2025.118863_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12253-015-9996-6","article-title":"Clinicopathological variation of lauren classification in gastric cancer","volume":"22","author":"Chen","year":"2016","journal-title":"Pathol. Oncol. Res"},{"key":"10.1016\/j.biopha.2025.118863_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5230\/jgc.2022.22.e35","article-title":"Molecular pathology of gastric cancer","volume":"22","author":"Kim","year":"2022","journal-title":"J. Gastric Cancer"},{"key":"10.1016\/j.biopha.2025.118863_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/bjc.2011.215","article-title":"Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis","volume":"105","author":"Camargo","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118863_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102175","article-title":"Microsatellite instability in Gastric Cancer: Between lights and shadows","volume":"95","author":"Puliga","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.biopha.2025.118863_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.118863_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neo.2017.02.012","article-title":"Chromosomal instability in gastric cancer biology","volume":"19","author":"Maleki","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.biopha.2025.118863_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","article-title":"Signaling pathways and therapeutic interventions in gastric cancer","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2025.118863_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cam4.1274","article-title":"Medical management of gastric cancer: a 2017 update","volume":"7","author":"Charalampakis","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.biopha.2025.118863_bib19","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1093\/annonc\/mdt232","article-title":"HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance","volume":"24","author":"Sheng","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2025.118863_bib20","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1177\/00031348221148359","article-title":"Management of gastric cancer","volume":"89","author":"Hall","year":"2023","journal-title":"Am. Surg."},{"key":"10.1016\/j.biopha.2025.118863_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4062\/biomolther.2023.196","article-title":"Current development status of cytokines for cancer immunotherapy","volume":"32","author":"Song","year":"2024","journal-title":"Biomol. Ther. (Seoul. )"},{"key":"10.1016\/j.biopha.2025.118863_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejca.2022.08.023","article-title":"Recent progress and current challenges of immunotherapy in advanced\/metastatic esophagogastric adenocarcinoma","volume":"176","author":"Moehler","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118863_bib23","first-page":"175","article-title":"The role of immunotherapy in esophageal and gastric cancer","volume":"22","author":"Dedecker","year":"2023","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.biopha.2025.118863_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1035276","article-title":"Current landscape and future directions of bispecific antibodies in cancer immunotherapy","volume":"13","author":"Wei","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118863_bib25","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","article-title":"Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial","volume":"402","author":"Janjigian","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118863_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2025.118863_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41571-024-00874-2","article-title":"Claudin 18.2 as a novel therapeutic target","volume":"21","author":"Nakayama","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118863_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15245742","article-title":"Claudin18.2 in advanced gastric cancer","volume":"15","author":"Inamoto","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118863_bib29","first-page":"2183","article-title":"CAR T cell therapy: A new era for cancer treatment (Review)","volume":"42","author":"Mohanty","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2025.118863_bib30","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.biopha.2025.118863_bib31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.20517\/cdr.2023.86","article-title":"New mechanisms of multidrug resistance: an introduction to the Cancer Drug Resistance special collection","volume":"6","author":"Gottesman","year":"2023","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.biopha.2025.118863_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu Rev. Med"},{"key":"10.1016\/j.biopha.2025.118863_bib33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1358\/dot.2020.56.7.3112071","article-title":"Progress and current status of molecule-targeted therapy and drug resistance in gastric cancer","volume":"56","author":"Chen","year":"2020","journal-title":"Drugs Today"},{"key":"10.1016\/j.biopha.2025.118863_bib34","article-title":"Molecular bases of mechanisms accounting for drug resistance in gastric adenocarcinoma","volume":"12","author":"Marin","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118863_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","article-title":"Noncoding RNAs in gastric cancer: implications for drug resistance","volume":"19","author":"Wei","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2025.118863_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","article-title":"Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches","volume":"347","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118863_bib37","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s12015-023-10593-3","article-title":"Cancer stem cells and the tumor microenvironment in tumor drug resistance","volume":"19","author":"Gao","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.biopha.2025.118863_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119933","article-title":"Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance","volume":"284","author":"Raei","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118863_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ijc.30039","article-title":"From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis","volume":"139","author":"Dhamija","year":"2016","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.biopha.2025.118863_bib40","doi-asserted-by":"crossref","first-page":"12385","DOI":"10.2147\/CMAR.S274599","article-title":"Multidrug resistance of gastric cancer: the mechanisms and chinese medicine reversal agents","volume":"12","author":"Huang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.biopha.2025.118863_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891652","article-title":"Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches","volume":"12","author":"Emran","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2025.118863_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2014.12.001","article-title":"Biological and therapeutic impact of intratumor heterogeneity in cancer evolution","volume":"27","author":"McGranahan","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2025.118863_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954992","article-title":"Managing the TME to improve the efficacy of cancer therapy","volume":"13","author":"Bilotta","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118863_bib44","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.ymthe.2025.01.012","article-title":"The high efficacy of claudin18.2-targeted CAR-T cell therapy in advanced pancreatic cancer with an antibody-dependent safety strategy","volume":"33","author":"Zhong","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2025.118863_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113370","article-title":"Treatment of gastric adenocarcinoma: A rapidly evolving landscape","volume":"195","author":"Taieb","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118863_bib46","doi-asserted-by":"crossref","first-page":"F867","DOI":"10.1152\/ajprenal.90264.2008","article-title":"Biology of claudins","volume":"295","author":"Angelow","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2025.118863_bib47","article-title":"Emerging targets in gastric and pancreatic cancer: Focus on claudin 18.2","volume":"611","author":"Tojjari","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118863_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16030679","article-title":"Claudin 18.2 as a New Biomarker in Gastric Cancer-What Should We Know?","volume":"16","author":"Mathias-Machado","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118863_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cells14161285","article-title":"Claudin18.2 as a promising therapeutic target in gastric cancer","volume":"14","author":"Poniewierska-Baran","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118863_bib50","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.21037\/tcr-19-1876","article-title":"Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer","volume":"9","author":"Hong","year":"2020","journal-title":"Transl. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118863_bib51","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s10120-022-01298-6","article-title":"Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab","volume":"25","author":"Bang","year":"2022","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.biopha.2025.118863_bib52","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/gutjnl-2023-329686","article-title":"Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer","volume":"73","author":"Zhang","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2025.118863_bib53","article-title":"CLDN18-ARHGAP26 function in gastric cancer and be a new therapeutic target by ABCG2 and ABCB1 pathway","volume":"42","author":"Li","year":"2022","journal-title":"Fst"},{"key":"10.1016\/j.biopha.2025.118863_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100905","article-title":"ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance","volume":"66","author":"Fan","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.biopha.2025.118863_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.03.001","article-title":"ABC transporters as mediators of drug resistance and contributors to cancer cell biology","volume":"26","author":"Fletcher","year":"2016","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.biopha.2025.118863_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231217967","article-title":"Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer","volume":"16","author":"Kubota","year":"2024","journal-title":"Ther. Adv. Med Oncol."},{"key":"10.1016\/j.biopha.2025.118863_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17121996","article-title":"Practical management of zolbetuximab administration: the project VYLOY initiative","volume":"17","author":"Narita","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118863_bib58","year":"2006"},{"key":"10.1016\/j.biopha.2025.118863_bib59","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJMc2409512","article-title":"Zolbetuximab in gastric or gastroesophageal junction adenocarcinoma","volume":"391","author":"Shitara","year":"2024","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2025.118863_bib60","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.1007\/s00432-023-05150-x","article-title":"Claudin18.2 expression in pulmonary mucinous adenocarcinoma","volume":"149","author":"Wang","year":"2023","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118863_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103663","article-title":"Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials","volume":"9","author":"Lordick","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.biopha.2025.118863_bib62","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12275-024-00133-0","article-title":"Genetically Engineered CLDN18.2 CAR-T Cells Expressing Synthetic PD1\/CD28 Fusion Receptors Produced Using a Lentiviral Vector","volume":"62","author":"Lee","year":"2024","journal-title":"J. Microbiol"},{"key":"10.1016\/j.biopha.2025.118863_bib63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-025-01744-9","article-title":"Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?","volume":"18","author":"Vo","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.118863_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094634","article-title":"Claudins in cancer: A current and future therapeutic target","volume":"25","author":"Hana","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118863_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.693016","article-title":"CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities","volume":"12","author":"Fischer","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118863_bib66","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(25)00860-8","article-title":"Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician\u2019s choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial","volume":"405","author":"Qi","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118863_bib67","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41591-022-01800-8","article-title":"Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results","volume":"28","author":"Qi","year":"2022","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2025.118863_bib68","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1111\/bph.16505","article-title":"Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer","volume":"181","author":"Ruixin","year":"2024","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118863_bib69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41419-025-07454-x","article-title":"CAR-T therapy dilemma and innovative design strategies for next generation","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118863_bib70","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41598-020-58864-0","article-title":"ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1","volume":"10","author":"Fultang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118863_bib71","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.7150\/ijbs.70120","article-title":"CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application","volume":"18","author":"Yang","year":"2022","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.biopha.2025.118863_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12935-024-03615-8","article-title":"Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer","volume":"25","author":"Marei","year":"2025","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.biopha.2025.118863_bib73","first-page":"1158","article-title":"Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancer","volume":"22","author":"Amawi","year":"2025","journal-title":"Cancer Biol. Med"},{"key":"10.1016\/j.biopha.2025.118863_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1165404","article-title":"IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models","volume":"14","author":"Shi","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118863_bib75","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2358590","article-title":"CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival","volume":"13","author":"Nie","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2025.118863_bib76","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1158\/1078-0432.CCR-24-1853","article-title":"Preclinical evaluation of AZD6422, an armored chimeric antigen receptor T cell targeting CLDN18.2 in gastric, pancreatic, and esophageal cancers","volume":"30","author":"Barrett","year":"2024","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118863_bib77","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1158\/1078-0432.CCR-18-0193","article-title":"Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept \u201c3G\u201d Trial","volume":"24","author":"Yong","year":"2018","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118863_bib78","article-title":"Expression and prognostic analysis of CLDN18 and Claudin18.2 in lung adenocarcinoma","volume":"238","author":"Liu","year":"2022","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.biopha.2025.118863_bib79","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118863_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114542","article-title":"Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update","volume":"239","author":"Engle","year":"2022","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118863_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100682","article-title":"Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors","volume":"50","author":"Dallavalle","year":"2020","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.biopha.2025.118863_bib82","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118863_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061894","article-title":"CAR-T Cell Therapy-An Overview of Targets in Gastric Cancer","volume":"9","author":"B\u0119bnowska","year":"2020","journal-title":"J. Clin. Med"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:12:23Z","timestamp":1777014743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225010571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":83,"alternative-id":["S0753332225010571"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118863","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative CAR-T approaches targeting Claudin 18.2 to counteract drug resistance in gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118863"}}